Adipokines and insulin resistance in chronic hepatitis C.

Adipokines and insulin resistance in chronic hepatitis C. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Adipokines and insulin resistance in chronic hepatitis C. Abstract Text:

Ian Homer Y Cua,Jason M Hui,Priyanka Bandara,James G Kench,Geoffrey C Farrell,Geoffrey W McCaughan,Jacob George,Ian Homer Y Cua,Jason M Hui,Priyanka Bandara,James G Kench,Geoffrey C Farrell,Geoffrey W McCaughan,Jacob George,

Adipokines and insulin resistance in chronic hepatitis C. Publishing Authors By Initials

IH Cua,JM Hui,P Bandara,JG Kench,GC Farrell,GW McCaughan,J George,IH Cua,JM Hui,P Bandara,JG Kench,GC Farrell,GW McCaughan,J George,

For similar nutritional and metabolic diseases: metabolic diseases: glucose metabolism disorders: hyperinsulinism: insulin resistance research abstracts see: nutritional and metabolic diseases: metabolic diseases: glucose metabolism disorders: hyperinsulinism: insulin resistance research

PUBMED ID PMID:

MEDLINE DATE:

Adipokines and insulin resistance in chronic hepatitis C. Journal Published:

PUBLICATION TYPE: Letter

Journal: Hepatology (Baltimore, Md.)

VOLUME: 46

Page Numbers: 2050-1; author reply 2051

Journal Abbreviation: Hepatology

ISSN: 1527-3350

DAY: 10

MONTH: Dec

YEAR: 2007

Adipokines and insulin resistance in chronic hepatitis C. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8302946

Adipokines and insulin resistance in chronic hepatitis C. Keywords Mesh Terms:

KEYWORDS: Insulin Resistance

MESH TERMS: physiopathology

Chemical & Substance for Abstract: Adipokines and insulin resistance in chronic hepatitis C. Information

Substance Name: Adipokines

Registry Number: 0

Grant and Affiliation Information for Adipokines and insulin resistance in chronic hepatitis C.

AFFILIATION:

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hepatology

REFSOURCE: Hepatology. 2007 Jul;46(1):66-73

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Adipokines and insulin resistance in chronic hepatitis C Related Publications

• A 70-year-old stock-breeder with tricuspid valve and defibrillator lead brucella endocarditis.
• Adipokines and insulin resistance in chronic hepatitis C.
• Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation.
• An extranodal NK/T cell lymphoma, nasal type, with specific immunophenotypic and genotypic features.
• Angioimmunoblastic T-cell lymphoma-associated arthritis: case report and literature review.
• Campylobacter fetus bacteraemia in a healthy individual: clinical and therapeutical implications.
• Changes of liver and muscle enzymes activity in patients with rigor.
• Epidemiological evidence for the non-random clustering of the components of the metabolic syndrome: multicentre study of the Mediterranean Group for the Study of Diabetes.
• Hepatic steatosis in chronic hepatitis B develops due to host metabolic factors: a comparative approach with genotype 1 chronic hepatitis C.
• Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
• Myelodysplastic syndrome presenting as acquired ichthyosis.
• Performance Characteristics of Microparticle Enzyme and Chemiluminescence Immunoassays for Measurement of Anti-HBc Immunoglobulin M in Sera of Patients with HBeAg-Negative Chronic Hepatitis B Virus Infection.
• Pseudohyperkalemia in serum: a new insight into an old phenomenon.
• Sensorineural hearing loss complicating severe rickettsial diseases: report of two cases.
• Serum adipokine levels in chronic liver diseases: Association of resistin levels with fibrosis severity.
• Serum apoptotic caspase activity as a marker of severity in HBeAg-negative chronic hepatitis B virus infection.
• Severe rhabdomyolysis with hypoglycemia in an adult patient with carnitine palmitoyltransferase II deficiency.
• Systemic Vasculitis With Gastrointestinal Involvement in an HIV-Infected Adult.
• Therapeutic strategies in the management of patients with chronic hepatitis B virus infection.
• Usefulness of enzyme-linked immunosorbent assay (elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment. Addendum.
• Usefulness of enzyme-linked immunospot assay (elispot) compared to tuberculin skin testing for latent tuberculosis screening in rheumatic patients scheduled for anti-tumor necrosis factor treatment.